Centre of Evidence Based Dermatology
  • Print

CEBD Coronavirus Dermatology Resource

 

Guidelines on coronavirus or relevant for coronavirus

 

Dermatology-specific guidelines and policies on coronavirus

NICE guideline [NG169] - COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response
https://www.nice.org.uk/guidance/ng169

NICE guideline [NG174] - COVID-19 rapid guideline: children and young people who are immunocompromised
https://www.nice.org.uk/guidance/NG174

British Association of Dermatologists (BAD) - Advice for Dermatology HCPs [health care professionals] during Covid-19 pandemic
http://www.bad.org.uk/healthcare-professionals/covid-19
#This BAD web page has guidance on various topics including dermatology service delivery, personal protection, and management of specific patient groups during the coronavirus epidemic. It also links to advice for the public from the BAD.

American Academy of Dermatology (AAD) - Managing your practice through the COVID-19 outbreak
https://www.aad.org/member/practice/managing/coronavirus
#This AAD web page has guidance on topics including dermatology service delivery, personal protection, patients on biologics and iPLEDGE patients.

British Dermatological Nursing Group (BDNG) - Covid-19
https://bdng.org.uk/covid-19/

Royal College of Radiologists - Guidelines for follow-up and SACT for melanoma during COVID-19 pandemic (PDF)
https://www.rcr.ac.uk/sites/default/files/melanoma-treatment-covid19.pdf

Royal College of Radiologists - Non-melanoma skin cancer (NMSC) and COVID-19 (PDF)
https://www.rcr.ac.uk/sites/default/files/non-melanoma-skin-cancer-covid19.pdf

International Eczema Council - Statement on COVID-19
https://www.eczemacouncil.org/news/iec-statement-on-covid-19/

International Psoriasis Council - Statement on the Coronavirus (COVID-19) Outbreak
https://www.psoriasiscouncil.org/blog/Statement-on-COVID-19-and-Psoriasis.htm

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments.
Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Gondo G, Heydon S, Koons S, Ritchlin CT.
J Am Acad Dermatol. 2021 Jan 7:S0190-9622(21)00016-5. doi: 10.1016/j.jaad.2020.12.058. Online ahead of print. Guideline.
https://doi.org/10.1016/j.jaad.2020.12.058

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations.
Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, De Jong E, Garcia-Doval I, Gisondi P, Kaur-Knudsen D, Mahil S, Mälkönen T, Maul JT, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt KM, Sator PG, Schmitt-Egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C.
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):281-317. doi: 10.1111/jdv.16926. Guideline.
https://doi.org/10.1111/jdv.16926

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.
Yim RM, Singh I, Armstrong AW.
Dermatol Online J. 2020 Oct 15;26(10):13030/qt0j5150df. Summary of international guidelines.
https://escholarship.org/uc/item/0j5150df

European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.
Thyssen JP, Vestergaard C, Barbarot S, de Bruin-Weller MS, Bieber T, Taieb A, Seneschal J, Cork MJ, Paul C, Flohr C, Weidinger S, Trzeciak M, Werfel T, Heratizadeh A, Darsow U, Simon D, Torrelo A, Chernyshov PV, Stalder JF, Gelmetti C, Szalai Z, Svensson Å, von Kobyletzki LB, De Raeve L, Fölster-Holst R, Christen-Zaech S, Jan Hijnen D, Gieler U, Gutermuth J, Bangert C, Spuls PI, Kunz B, Ring J, Wollenberg A, Deleuran M.
J Eur Acad Dermatol Venereol. 2021 Feb 15. doi: 10.1111/jdv.17167. Online ahead of print. Guideline.
https://doi.org/10.1111/jdv.17167

Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19.
Arenbergerova M, Lallas A, Nagore E, Rudnicka L, Forsea A, Pasek M, Meier F, Peris K, Olah J, Posch C.
J Eur Acad Dermatol Venereol. 2021 Mar 29. doi: 10.1111/jdv.17252. Online ahead of print. Guideline.
https://doi.org/10.1111/jdv.17252

Best-Practices for Preventing Skin Injury Beneath Personal Protective Equipment During the COVID-19 Pandemic: A Position Paper from the National Pressure Injury Advisory Panel (NPIAP).
Padula WV, Cuddigan J, Ruotsi L, Black JM, Brienza D, Capasso V, Cox J, Delmore B, Holden-Mount S, Munoz N, Nie AM, Pittman J, Sonenblum S, Tescher A; National Pressure Injury Advisory Panel (NPIAP).
J Clin Nurs. 2021 Feb 3. doi: 10.1111/jocn.15682. Online ahead of print. Guideline.
https://doi.org/10.1111/jocn.15682

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic.
Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY.
J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16720. [Epub ahead of print]. Guideline.
https://doi.org/10.1111/jdv.16720

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.
Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.
J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557. [Epub ahead of print]. Guideline / commentary.
https://doi.org/10.1111/jdv.16557

IADVL Position Statement and Recommendations on Post Lockdown Dermatology Practice Amidst the Covid -19 Pandemic (IADVL Academy and IADVL Executive Committee).
Khurana A, Pandhi D.
Indian Dermatol Online J. 2020 May 18;11(4):520-525. doi: 10.4103/idoj.IDOJ_334_20. eCollection 2020 Jul-Aug. Guideline.
https://doi.org/10.4103/idoj.idoj_334_20

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo RV 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT.
J Am Acad Dermatol. 2020 Sep 3:S0190-9622(20)32544-5. doi: 10.1016/j.jaad.2020.09.001. Online ahead of print. Guideline.
https://doi.org/10.1016/j.jaad.2020.09.001

Systemic Immunosuppressive Therapy for Inflammatory Skin Diseases in Children: Expert-Consensus-Based Guidance for Clinical Decision Making During the COVID-19 Pandemic.
Reynolds SD, Mathur AN, Chiu YE, Brandling-Bennett HA, Pope E, Siegel MP, Holland KE, Paller AS, Siegfried EC, Tom WL, Lara-Corrales I, Tollefson MM, Maguiness S, Eichenfield LF, Sugarman J, Frieden IJ, Oza VS, Cipriano SD, Huang JT, Shah SD, Lauren CT, Castelo-Soccio L, McMahon P, Cordoro KM.
Pediatr Dermatol. 2020 Apr 22. doi: 10.1111/pde.14202. [Epub ahead of print]. Guideline.
https://doi.org/10.1111/pde.14202

Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement.
Vultaggio A, Agache I, Akdis CA, Akdis M, Bavbek S, Bossios A, Bousquet J, Boyman O, Chaker AM, Chan S, Chatzipetrou A, Feleszko W, Firinu D, Jutel M, Kauppi P, Klimek L, Kolios A, Kothari A, Kowalski ML, Matucci A, Palomares O, Pfaar O, Rogala B, Untersmayr E, Eiwegger T.
Allergy. 2020 Jun 5. doi: 10.1111/all.14407. [Epub ahead of print]. Guideline / position statement.
https://doi.org/10.1111/all.14407

COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australia/New Zealand consensus statement.
Wang C, Rademaker M, Baker C, Foley P.
Australas J Dermatol. 2020 Apr 7. doi: 10.1111/ajd.13313. [Epub ahead of print]. Guideline.
https://doi.org/10.1111/ajd.13313

Psoriasis management during the COVID-19 pandemic: Recommendations by SIG Psoriasis (IADVL Academy).
Ganguly S, Parthasaradhi A, Thomas J, Arora S, Kumar P, Pradhan S, Saraswat A, Singh V, Komeravalli H.
Indian Dermatol Online J. 2021 Jan 16;12(1):58-65. doi: 10.4103/idoj.IDOJ_685_20. eCollection 2021 Jan-Feb. Review & recommendations.
https://doi.org/10.4103/idoj.idoj_685_20

Navigating Immunosuppression in a Pandemic: A Guide for the Dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists.
Niaki OZ, Anadkat MJ, Chen ST, Fox LP, Harp J, Micheletti RG, Nambudiri VE, Pasieka HB, Shinohara MM, Rosenbach M, Merola JF.
J Am Acad Dermatol. 2020 Jun 19. pii: S0190-9622(20)31149-X. doi: 10.1016/j.jaad.2020.06.051. [Epub ahead of print]. Guideline / review.
https://doi.org/10.1016/j.jaad.2020.06.051

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis.
Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C.
J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411. [Epub ahead of print]. Guideline.
https://www.ncbi.nlm.nih.gov/pubmed/32223003

Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up.
Nahm SH, Rembielak A, Peach H, Lorigan PC; Contributing Clinicians.
Clin Oncol (R Coll Radiol). 2020 Jul 1. pii: S0936-6555(20)30273-9. doi: 10.1016/j.clon.2020.06.017. [Epub ahead of print] No abstract available. Consensus guideline.
https://doi.org/10.1016/j.clon.2020.06.017

Management of primary skin cancer during a pandemic: Multidisciplinary recommendations.
Baumann BC, MacArthur KM, Brewer JD, Mendenhall WM, Barker CA, Etzkorn JR, Jellinek NJ, Scott JF, Gay HA, Baumann JC, Manian FA, Devlin PM, Michalski JM, Lee NY, Thorstad WL, Wilson LD, Perez CA, Miller CJ.
Cancer. 2020 Jun 1. doi: 10.1002/cncr.32969. [Epub ahead of print]. Guideline.
https://doi.org/10.1002/cncr.32969

Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts.
Murrell DF, Lucky AW, Salas-Alanis JC, Woodley DT, Palisson F, Natsuga K, Nikolic M, Ramirez-Quizon M, Paller AS, Lara-Corrales I, Barzegar MA, Sprecher E, Has C, Laimer M, Bruckner AL, Bilgic A, Nanda A, Purvis D, Hovnanian A, Murat-Sušić S, Bauer J, Kern JS, Bodemer C, Martin LK, Mellerio J, Kowaleski C, Robertson SJ, Bruckner-Tuderman L, Pope E, Marinkovich MP, Tang JY, Su J, Uitto J, Eichenfield LF, Teng J, Aan Koh MJ, Lee SE, Khuu P, Rishel HI, Sommerlund M, Wiss K, Hsu CK, Chiu TW, Martinez AE.
J Am Acad Dermatol. 2020 Jul 15. pii: S0190-9622(20)32195-2. doi: 10.1016/j.jaad.2020.06.1023. [Epub ahead of print] No abstract available. Guideline.
https://doi.org/10.1016/j.jaad.2020.06.1023

Managing Psoriasis Consultations During the COVID-19 Pandemic: Recommendations from the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (AEDV).
Belinchón I, Puig L, Ferrándiz L, De La Cueva P, Carrascosa JM; en nombre del Grupo de Psoriasis de la AEDV.
Actas Dermosifiliogr. 2020 Jun 6. pii: S0001-7310(20)30164-2. doi: 10.1016/j.ad.2020.05.004. [Epub ahead of print] English, Spanish. No abstract available. Guideline.
https://doi.org/10.1016/j.ad.2020.05.004

Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
Carrascosa JM, Pastor-Nieto MA, Ruiz-Gonzalez I, Silvestre JF, Borrego L, Gatica-Ortega ME, Gimenez-Arnau AM; en representación del, Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC).
Actas Dermosifiliogr. 2020 Jul 2. pii: S0001-7310(20)30221-0. doi: 10.1016/j.ad.2020.06.003. [Epub ahead of print] English, Spanish. Guideline.
https://doi.org/10.1016/j.ad.2020.06.003

Recommendations on Sun Exposure and Photoprotection Following Easing of the COVID-19 Pandemic Lockdown: Spanish Photobiology Group of the Spanish Academy of Dermatology and Venerology (AEDV).
Aguilera J, de Gálvez MV, Aguilera P, de Troya M, Gilaberte Y; del Grupo Español de Fotobiología de la AEDV.
Actas Dermosifiliogr. 2020 Jun 18. pii: S0001-7310(20)30183-6. doi: 10.1016/j.ad.2020.06.001. [Epub ahead of print] English, Spanish. No abstract available. Guideline / review.
https://doi.org/10.1016/j.ad.2020.06.001

Management of Phototherapy Units During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Photobiology Group.
Aguilera P, Gilaberte Y, Pérez-Ferriols A, de Argila D, Aguilera J, de Galvez MV, Granados MT, Gardeazabal J, Carrascosa JM; del Grupo Español de Fotobiología.
Actas Dermosifiliogr. 2020 Jul 14. pii: S0001-7310(20)30236-2. doi: 10.1016/j.ad.2020.07.001. [Epub ahead of print] English, Spanish. No abstract available. Guideline.
https://doi.org/10.1016/j.ad.2020.07.001

Recommendations for phototherapy during the COVID-19 pandemic.
Lim HW, Feldman SR, Van Voorhees AS, Gelfand JM.
J Am Acad Dermatol. 2020 Apr 24. pii: S0190-9622(20)30707-6. doi: 10.1016/j.jaad.2020.04.091. [Epub ahead of print] No abstract available. Guideline.
https://doi.org/10.1016/j.jaad.2020.04.091

Resumption of laser/IPL skin services post COVID-19 lockdown-British Medical Laser Association (BMLA) guidance document.
Madan V.
Lasers Med Sci. 2020 Jun 27. doi: 10.1007/s10103-020-03086-z. [Epub ahead of print]. Guideline.
https://doi.org/10.1007/s10103-020-03086-z 

Management of infantile hemangiomas during the COVID pandemic.
Frieden IJ, Püttgen KB, Drolet BA, Garzon MC, Chamlin SL, Pope E, Mancini AJ, Lauren CT, Mathes EF, Siegel DH, Gupta D, Haggstrom AN, Tollefson MM, Baselga E, Morel KD, Shah SD, Holland KE, Adams DM, Horii KA, Newell BD, Powell J, McCuaig CC, Nopper AJ, Metry DW, Maguiness S; Hemangioma Investigator Group.
Pediatr Dermatol. 2020 Apr 16. doi: 10.1111/pde.14196. [Epub ahead of print]. Guideline.
https://doi.org/10.1111/pde.14196

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.
Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.
J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525. [Epub ahead of print]. Guideline.
https://doi.org/10.1111/jdv.16525

United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic.
Zic JA, Ai W, Akilov OE, Carter JB, Duvic M, Foss F, Girardi M, Gru AA, Kim E, Musiek A, Olsen EA, Schieke SM, Shinohara M, Zain JM, Geskin LJ.
J Am Acad Dermatol. 2020 Apr 16. pii: S0190-9622(20)30662-9. doi: 10.1016/j.jaad.2020.04.049. [Epub ahead of print] No abstract available. Guideline.
https://doi.org/10.1016/j.jaad.2020.04.049

Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.
Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M.
J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593. [Epub ahead of print]. Guideline.
https://doi.org/10.1111/jdv.16593

Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.
Tam LS, Tanaka Y, Handa R, Chang CC, Cheng YK, Isalm N, Li M, Lorenzo JP, Song YW, Yamamoto K, Zeng X, Haq SA.Int J Rheum Dis. 2020 May 27. doi: 10.1111/1756-185X.13863. [Epub ahead of print] No abstract available. Guideline / position statement.
https://doi.org/10.1111/1756-185X.13863

COVID-19 Pandemic: Consensus Guidelines for Preferred Practices in an Aesthetic Clinic.
Kapoor KM, Chatrath V, Boxley SG, Nurlin I, Snozzi P, Demosthenous N, Belo V, Chan WM, Kanaris N, Kapoor P.
Dermatol Ther. 2020 May 16:e13597. doi: 10.1111/dth.13597. [Epub ahead of print]. Guideline.
https://doi.org/10.1111/dth.13597

Dermatosurgery Practice and Implications of COVID-19 Pandemic: Recommendations by IADVL SIG Dermatosurgery (IADVL Academy).
Lahiry AK, Grover C, Mubashir S, Ashique KT, Madura C, Goyal N, Talwar A, Gupta S, Gulanikar AD, Das S.
Indian Dermatol Online J. 2020 May 10;11(3):333-336. doi: 10.4103/idoj.IDOJ_237_20. eCollection 2020 May-Jun. Guideline.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367579/

Lasers Use in Dermatology Practice in the Evolving COVID-19 Scenario: Recommendations by SIG Lasers (IADVL Academy).
Dhawan S, Kumari P, De A, Pall A, Pudukadan D, Romi E, Jyothy K, Selvam MD, Mrigpuri S, Shah S, Thurakkal S, Trivedi S.
Indian Dermatol Online J. 2020 May 10;11(3):337-342. doi: 10.4103/idoj.IDOJ_239_20. eCollection 2020 May-Jun. Guideline.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367557/

Dermoscopy Practice during COVID-19 Pandemic: Recommendations by SIG Dermoscopy (IADVL Academy).
Jakhar D, Bhat YJ, Chatterjee M, Keshavmurthy V, Ankad BS, Jha AK, Jayasree P, Save S, Mukherjee SS, Mehta H, Udare S, Beergouder S.
Indian Dermatol Online J. 2020 May 10;11(3):343-344. doi: 10.4103/idoj.IDOJ_231_20. eCollection 2020 May-Jun. Guideline.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367558/

Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by SIG Leprosy (IADVL Academy).
Rathod S, Suneetha S, Narang T, Bhardwaj A, Gupta SK, Kamoji SG, Ashwini PK, Pradhan S, Rather SP, Patnaik S, Shankar V, Jandhyala S, Rao PN, Dogra S.
Indian Dermatol Online J. 2020 May 10;11(3):345-348. doi: 10.4103/idoj.IDOJ_234_20. eCollection 2020 May-Jun. Guideline.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367564/

 

Guidelines on occupational and contact dermatitis, and hand washing

NHS England - Helping prevent facial skin damage beneath personal protective equipment (PDF)
https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/C0129_Preventing-skin-damage-under-PPE_9-April.pdf

Hand Hygiene During COVID-19: Recommendations from the American Contact Dermatitis Society.
Rundle CW, Presley CL, Militello M, Barber C, Powell DL, Jacob SE, Atwater AR, Watsky KL, Yu J, Dunnick CA.
J Am Acad Dermatol. 2020 Jul 21:S0190-9622(20)32256-8. doi: 10.1016/j.jaad.2020.07.057. Online ahead of print. Guideline / review.
https://doi.org/10.1016/j.jaad.2020.07.057

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.
Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.
J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557. [Epub ahead of print]. Guideline / commentary.
https://doi.org/10.1111/jdv.16557

Diagnosis, management and prevention of occupational contact dermatitis. Concise Guidance to Good Practice Series, Number 13.
Royal College of Physicians, British Association of Dermatologists, British Occupational Health Research Foundation, Faculty of Occupational Medicine, Health and Work Development Unit, NHS Plus.
London: Royal College of Physicians, April 2011.
http://www.bad.org.uk/shared/get-file.ashx?id=792&itemtype=document

British Association of Dermatologists' guidelines for the management of contact dermatitis 2017.
Johnston GA, Exton LS, Mohd Mustapa MF, Slack JA, Coulson IH, English JS, Bourke JF.
Br J Dermatol. 2017 Feb;176(2):317-329. doi: 10.1111/bjd.15239. Guideline.
https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.15239

Update to device-related pressure ulcers: SECURE prevention. COVID-19, face masks and skin damage.
Gefen A, Ousey K.
J Wound Care. 2020 May 2;29(5):245-259. doi: 10.12968/jowc.2020.29.5.245. Guidance / consensus statement.
https://doi.org/10.12968/jowc.2020.29.5.245

WHO guidelines on hand hygiene in health care
https://www.who.int/gpsc/5may/tools/9789241597906/en/

Royal College of Physicians - Latex Allergy: Occupational Aspects of Management 2008
https://www.rcplondon.ac.uk/guidelines-policy/latex-allergy-occupational-aspects-management-2008

 

Guidelines and policies on skin protection for healthcare workers

NHS England - Helping prevent facial skin damage beneath personal protective equipment (PDF)
https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/C0129_Preventing-skin-damage-under-PPE_9-April.pdf

Consensus of Chinese experts on protection of skin and mucous membrane barrier for healthcare workers fighting against coronavirus disease 2019.
Yan Y, Chen H, Chen L, Cheng B, Diao P, Dong L, Gao X, Gu H, He L, Ji C, Jin H, Lai W, Lei T, Li L, Li L, Li R, Liu D, Liu W, Lu Q, Shi Y, Song J, Tao J, Wang B, Wang G, Wu Y, Xiang L, Xie J, Xu J, Yao Z, Zhang F, Zhang J, Zhong S, Li H, Li H.
Dermatol Ther. 2020 Mar 13:e13310. doi: 10.1111/dth.13310. [Epub ahead of print]. Guideline.
https://doi.org/10.1111/dth.13310

 

General coronavirus guidelines and policies

World Health Organization (WHO) - Coronavirus disease (COVID-19) Pandemic
https://www.who.int/emergencies/diseases/novel-coronavirus-2019

National Institute for Health and Care Excellence (NICE) - Coronavirus (COVID-19)
https://www.nice.org.uk/covid-19

National Institute for Health and Care Excellence (NICE) - COVID-19 rapid guideline: delivery of systemic anticancer treatments : guidance (NG161)
https://www.nice.org.uk/guidance/ng161

Public health England - Coronavirus (COVID-19): guidance
https://www.gov.uk/government/collections/coronavirus-covid-19-list-of-guidance

Health Protection Scotland – COVID-19 Guidance
https://www.hps.scot.nhs.uk/guidance/

Public Health Wales - Coronavirus advice
https://phw.nhs.wales/

Public Health Agency (Northern Ireland) – Coronavirus advice
https://www.publichealth.hscni.net/

European Centre for Disease Prevention and Control - Coronavirus disease
https://www.ecdc.europa.eu/en

US Centers for Disease Control and Prevention (CDC) - Coronavirus (COVID-19)
https://www.cdc.gov/coronavirus/2019-ncov/index.html

Royal College of Nursing (RCN) - COVID-19
https://www.rcn.org.uk/

Royal College of General Practitioners (RCGP) - COVID-19
https://www.rcgp.org.uk/covid-19.aspx

 

Back to CEBD Coronavirus Dermatology Resource Homepage

Centre of Evidence Based Dermatology

The University of Nottingham
King's Meadow Campus
Lenton Lane
Nottingham, NG7 2NR


telephone: +44 (0) 115 823 1048
email:cebd@nottingham.ac.uk